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Membrane fusion is a key event in many biological processes. These processes are controlled by various fusogenic agents of which
proteins and peptides from the principal group. The fusion process is characterized by three major steps, namely, inter membrane
contact, lipid mixing forming the intermediate step, pore opening and ﬁnally mixing of inner contents of the cells/vesicles.
These steps are governed by energy barriers, which need to be overcome to complete fusion. Structural reorganization of big
molecules like proteins/peptides, supplies the required driving force to overcome the energy barrier of the diﬀerent intermediate
steps. Small molecules/ions do not share this advantage. Hence fusion induced by small molecules/ions is expected to be diﬀerent
from that induced by proteins/peptides. Although several reviews exist on membrane fusion, no recent review is devoted solely
to small moleculs/ions induced membrane fusion. Here we intend to present, how a variety of small molecules/ions act as
independent fusogens. The detailed mechanism of some are well understood but for many it is still an unanswered question.
Clearer understanding of how a particular small molecule can control fusion will open up a vista to use these moleucles instead of
proteins/peptides to induce fusion both in vivo and in vitro fusion processes.
1.Introduction
Membrane fusion is the process of merging of adjacent cells,
vesicles,orliposomes tomixtheirinner contentsandtoform
a large fused cell, vesicle, or liposome [1]. It is an integral
process of many biological events starting from gamete for-
mation by fertilization [2, 3], viral infection of host cells [4,
5], endocrine hormone secretion [6], and neuronal signaling
[7]. Thus, membrane fusion is essential, not only for the
initiation of life but also to carry forward it successfully
without any diﬃculties. The process of membrane fusion is
extremely important for study, in order to ﬁnd out a way to
control it and to make the process more useful in various in
vitro biochemical processes and in biotechnology [8].
The process of membrane fusion varies widely in diﬀer-
ent systems. For example, fusion of yeast vacuoles (dimen-
sion-micron level) occur through an area of contact, which is
almost 10000-fold larger compared to that during exocytosis
of synaptic vesicles. Whereas, the vacuoles take minutes
to undergo fusion, the synaptic vesicles take milliseconds,
which means ∼10000-fold shorter times than yeast vacuoles
[9]. Fusion both in vivo and in vitro is usually induced by
external agents called fusogens. The most common fusogens
are large molecules like proteins and peptides. There are
also other types of fusogens which will be detailed later
in the text. Depending on the nature of the fusogens, the
exact mechanism varies. By “mechanism,” we mean the
way a fusogenic agent will induce the fusion process.
Despite the diversities in the mechanism, the process is
characterized by similar basic steps in all kinds of membrane
fusion (Figure 1). In order to fuse two membranes, they
must ﬁrst be brought together such that their surfaces
become closely apposed. This requires removal of aqueous
environment associated with the polar head groups and is
expected to be one of the most energetically demanding
process [10]. This is followed by a local disruption of the
organized bilayer which results in fusion of outer leaﬂet
of each membrane forming the hemifused, often “stalk-
like” intermediate. Next, reorganization of the inner lipid
leaﬂet results in pore opening and mixing of inner aqueous
contents to complete the fusion process. Each intermediate
state of the fusion process is characterized by their speciﬁc2 Journal of Lipids
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Figure 1: Basic Steps of membrane fusion. (a) Membrane contact,
(b) outer leaﬂet lipid mixing to form the hemifused state, and (c)
inner leaﬂet lipid mixing and pore formation and content mixing.
conformational energy which is the associated potential
energy of the state. The diﬀerence in the conformational
energy between state 2 and state 1 provides the potential
energy barrier. This needs to be overcome for the fusion to
proceed. A fusogen provides this energy to overcome the
barrier which is translated into the required kinetic energy
that drives the membrane from one intermediate step to the
next by structural reorganization of the lipid molecules in
the bilayer. If the amount of energy supplied by the fusogens
isnot enoughtostrikethecorrect “structureenergybalance,”
that is, the energy supplied is not adequate to form the
correct structure of the next intermediate, the fusion process
will not be able to proceed further.
The basic steps of membrane fusion are detailed below.
1.1. Vesicle Contact. It is van der Waal’s attractive interaction
that brings together the two membranes to undergo fusion.
The extent of this attractive force has been estimated accord-
ing to theDerjaguin-Landau-Verway-Overbeek (DLVO)the-
ory [11]. Besides van der Waal’s attractive force, there are
hydration, electrostatic, and steric forces that produce strong
repulsive force adequate enough to prevent the close contact
of the approaching membranes [12]. The interplay of these
two types of opposing forces makes a vesicle suspension
stable at physiologically relevant conditions. Generally, the
intercellular or intervesicular distance of ∼2nm is mostly
due to the prevailing excessive hydration repulsion that acts
in between two approaching membranes [13].
T h e r ea r es e v e r a lw a y st oi n i t i a t et h i sa p p r o a c ht om a k e
a close contact between two fusing vesicles. Diminishing the
intermembrane hydration repulsion is one of the methods
to initiate membrane contact [13]. The hydrophilic, aqueous
environment betweentwo approaching hydrophobicbilayers
i st h eo r i g i no ft h eh y d r a t i o nr e p u l s i o n .I nf a c t ,l o w e r i n go f
the number of water binding sites or charge on the mem-
branes decreases the lipid bilayer repulsion, which facilitates
close contact of the membranes [14]. Diﬀerent fusogenic
agents have diﬀerent mechanisms to diminish this hydration
repulsion. These fusogens can act either by decreasing
bilayer surface charge density, polarity or by increasing hy-
drophobicity of the intermembrane hydrophilic region by
dehydrating the intermediate environment as in case of poly
(ethylene glycol) [15, 16]. An estimated >100 atm pressure
is required to mix or merge the outer leaﬂet of contacting
membranes [17], which is very high. To minimize the work
required for lipid merger, initial contact proceeds is expected
to through small, local point of contact. This leads to the
participation ofminimum number oflipid moleculesduring
formationofthefusionintermediates. Thus,mergingoflipid
membranes becomes a very site-restricted process, acting in
some cases within a very small area of approximately 10nm2
[18].
1.2. Vesicle Merging. After the close contact of the two app-
roaching membranes or lipid bilayers, a temporary disorder
of the bilayer lipids in the contact region is required for
vesicular merging. There are severalways to achieve this. The
lipid composition of the vesicles plays a crucial role during
the merging ofmembranes. Accordingto aschool ofthought
[19], during the merging of lipids, considerable amount of
lipids undergo a transition from lamellar bilayer phase (L) to
inverted hexagonal phase (HII)( Figure 2)[ 20]a tt h ec o n t a c t
site. It has been proposed that, the transition from L → HII
is essential for the successful mixing of the outer bilayer of
lipids to promote fusion. There are several inverted hexago-
nal phase forming lipids, namely, phosphatidylethanolamine
(PE) [21] and cardiolipin [22] which inﬂuence the required
structural/orientation change of the lipid molecules during
merging. There are a number of molecules like drugs [23],
surfactants [24], solvents [25], and metabolites [26]w h i c h
can inﬂuence the L → HII phase transition and thereby have
the propensity to act as fusogens.
Another factor that facilitates the merging of the lipids
and thus promotes fusion is accumulation of defects or per-
turbations or ﬂuctuations in the contact region. Defects can
be introduced either by external agents like fusogens, or
by alteration of some physical parameters. It is well known
that temperature [27], membrane curvature [28], surface
tension [27], and so forth, can incorporate stress and strain
in the membranes which introduce defects. The eﬀect of
temperature generally maximizes near the phase transition
temperature of the lipid bilayer where a minute change in
temperature causes signiﬁcant defect or ﬂuctuations in the
bilayer that is enough to induce fusion [27]. Surface tension,
which represents the surface density of membrane surface
free energy, is another physical parameter that is known
to induce fusion. Increase in surface tension supplies the
requisite energy to overcome the barriers of diﬀerent steps
of fusion to complete the process [16, 27].
Small lipid vesicles of diameter ∼45nm do not have
suﬃcient number of lipid molecules for forming inverted
hexagonal phase, yet they are known to fuse extensively
[29]. The high curvature induces defects in membranes in
such a way that the membranes get the required energy for
fusion. The spontaneous curvature of the lipid molecules is a
critical factor for lipid merging and intermediate formation.Journal of Lipids 3
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Figure 2: Diﬀerent phases of lipid: (a) lamellar (L) phase and (b) inverted hexagonal (HII)p h a s e .
Spontaneous curvature of lipids means the curvature of the
lipidmonolayerachievedin theaqueoussolutionsinabsence
of any constraints. It is determined by the molecular struc-
ture of lipids within the monolayer. Spontaneous curvature,
which is an inherent property of the lipid molecules, dictates
the eﬀective shape of the lipids in the bilayer [30, 31]. Lipids
having positive spontaneous curvature lead to an inverted
cone-shaped structure. Whereas, lipids having negative
spontaneous curvature have cone-like shape. Lipids with
cylindrical eﬀective shape have zero spontaneous curvature
[32]. Thus, the choice of speciﬁc lipid molecules can also
control the process of fusion, by dictating the nature of
the spontaneous curvature. It is now established that the
stress and strain associated with high membrane curvature,
provide enough perturbation and energy source for fusion
[27].
1.3.Membrane Fusion Assays. Before goingintothe detailsof
the use of various fusogenic agents, we will brieﬂy describe
how the process of fusion is monitored. Apart from imag-
ing techniques, namely, transmission electron microscopy
(TEM), scanning electron microscopy (SEM), freeze frac-
ture microscopy, confocal microscopy, and ﬂuorescence
microscopy that can monitor fusion of large cells or vesicles,
there are ﬂuorescence assays which can monitor thefusion of
vesicles having diameter as small as ∼20nm.
Fluorescence assays are used to monitor the initial step
of fusion, that is, lipid mixing, and also the ﬁnal step of
membrane fusion, that is, the mixing of inner contents of
the vesicles. Leakage of inner contents of vesicles through
the membranes is a process which occurs spontaneously
and continuously in thevesicles. Spontaneous leakageoccurs
simultaneously with content mixing and lipid mixing.
Measurement of leakage is necessary to get a quantitative
idea about the extent of content mixing and lipid mixing.
Here, we describe the two principal assays mostly used in
the literature, namely, lipid mixing assay and content mixing
assay.
1.3.1. Lipid Mixing Assay. Lipid mixing is the preliminary
step of membrane fusion, where after the initial contact,
the lipid molecules from both the leaﬂet of the bilayer
mix together. This leads to the formation of the hemifu-
sion state that often extends to form a stalk like interme-
diate. Most commonly, Forster Resonance Energy Transfer
(FRET) between donor and acceptor molecules are used to
monitor lipid mixing. The widely used probesare, donor: N-
NBD-PE [N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihex-
adecanoyl-sn-glycero-3-phosphoethanolamine, triammoni-
um salt] and acceptor: N-Rh-PE [Lissamine rhodamine B-
1,2-dihexadecanoyl-sn-glycero-3-phospha- nolamine, trie-
thylammonium salt] [33]. One set of vesicles are prepa-
red by tagging them with both the donor and acceptor
probes, where the distance between the donor and acceptor
molecules are such that FRET occurs. These are mixed
with another set of vesicles without any probe. After fusion
of the two sets of vesicles, the optimum distance between
the donor-acceptor pair increases. This increased distance
between N-NBD-PE and N-Rh-PE decreases their FRET
eﬃciency and hence the ﬂuorescence ofthe donor, that is, N-
NBD-PE increases. The increase in ﬂuorescence of the donor
or the decrease in ﬂuorescence of the acceptor is monitored
to calculate the percentage lipid mixing as a function of time
[33, 34].
1.3.2. Content Mixing Assay. Content mixing is the mixing
of inner contents of the two fusing vesicles and is the ﬁnal
stage of membrane fusion. That is why the measurement of
content mixing is essential to show the successful completion
of the fusion process. Two types of assays are generally used
to probe content mixing. One is the Tb/DPA assay where
terbium chloride (TbCl3) and dipicolinic acid (DPA) are
used. The other assay is the ANTS (Aminonaphthalene-tri-
sulphonic acid)/DPX (p-Xylene bis(pyridinium) bromide)
assay [35, 36].
The Tb/DPA assay is done at pH > 5.0 and is generally
meant for vesicles of all sizes. In Tb/DPA assay, two sets4 Journal of Lipids
of vesicles are prepared, one encapsulated with TbCl3 and
another encapsulated with DPA. Though both Tb3+ and
DPA are nonﬂuorescent in nature, their complex is highly
ﬂuorescent,andtheﬂuorescenceoftheTb3+-DPAcomplexis
used tomonitor content mixing [36].Contentmixing results
in the formation of Tb3+-DPA complex which increases the
ﬂuorescence intensity. This is used to calculate percentage
content mixing as a function of time. To avoid ﬂuorescence
from Tb3+-DPA complexleaking outofthe vesicles,a power-
ful chelating ligand EDTA is added to the external buﬀerthat
breaks the Tb3+-DPA complex and makes a nonﬂuorescent
complex Tb3+-EDTA [35].
The ANTS/DPX assay is done at low pH (pH < 5.0),
where Tb/DPA assay is nonfunctional. Mostly large unil-
amellar vesicles (LUVs) fusion and giant unilamellar vesicles
(GUVs) fusion can be monitored using this assay [36]. The
ANTS/DPX assay is based on the collisional quenching of
the ANTS ﬂuorescence by the quencher DPX [37]. Two sets
of vesicles are prepared, one encapsulated with ﬂuorescent
probe ANTS and the other encapsulated with ﬂuorescence
quencher DPX. Due to fusion, the inner contents of the
vesicles get mixed together and the ﬂuorescence of ANTS
is quenched by DPX. The measurement of the decrease in
ﬂuorescence intensity gives the estimation of extent of
content mixing [36, 38].
2.FusionInducedby Different
FusogenicAgents
Membrane fusion requires direct or indirect participation
of diﬀerent external agents or fusogens. There are various
ways that a fusogenic agent can induce fusion. As has
been mentioned before, a crucial structure-energy balance is
required for every intermediate step of the fusion process.
Lack of which may prevent the completion of the process
or may cause the process to revert back to the initial
unfused stage [39, 40]. There are various kinds of fusogenic
agents available. Amongst them proteins and peptides are
most common in biological systems. Large molecules like
proteins and peptides can overcome the energy barrier of
theintermediatestepsofmembranefusionbyreorganization
of their structures which provide the driving force [41–46].
Hence, most fusion events both in vivo and in vitro are
induced by proteins and peptides. Small molecules and ions,
unlike proteins and peptides, cannot provide the necessary
driving forceby theirstructural reorganization toinduceand
complete membrane fusion.
Apart from proteins and peptides, there are lipids [47],
small organic ligands [48], metal ions [49], polymers [50],
and drugs [51] that can act as fusogens. The mechanism by
which diﬀerent fusogens induce fusion, varies widely. The
principal aim of this review is to probe the literature status
andthepossiblemodeofactionofsmallmoleculesorionson
membrane fusion. This is becausemembrane fusion induced
by more popular big molecules, namely, proteins or peptides
i saw e l l - s t u d i e da n dr e v i e w e dﬁ e l d[ 32, 42]. Several recent
reviews have been solely devoted to proteins- or peptides-
induced membrane fusion, where the mechanism has been
clearly elucidated. Reviews on membrane fusion induced by
small molecules and ions are rare in the literature. Since
the mechanism of fusion in this case is expected to be very
diﬀerent from those of big molecules as mentioned above,
we feel that this review is timely. Understanding the diﬀerent
mechanisms by which small molecules and ions induce
fusion, will allow the use of these agents to induce fusion
in a controlled manner in in vitro biochemical processes
necessary in biotechnology.
2.1. Positive Ions. Amongst all the small molecules, cations
were ﬁrst identiﬁed to have membrane fusogenic property.
A wide range of studies were done starting from early
seventies to late eighties on cations-induced fusion. From
almost two decades of work, two cations, namely, Ca2+ [52–
58]a n dM g 2+ [16, 59, 60] were found, which can induce
membrane fusion eﬀectively. Other cations like Mn2+ [49],
Zn2+ [61–63], La3+ [64], Sr3+ [16], and H+ [65]a l s oh a v e
some potential to induce membrane fusion, but Ca2+ is
the principal player. Ion binding to membranes, not only
resultsinscreeningofelectricchargesonmembranesurfaces,
but also modiﬁes surface polarity, which in turn alters the
hydration-dependent intermembrane repulsion [66].
2.1.1. Pure Ca2+-Induced Fusion. Being a cation, Ca2+ can
induce the fusion of anionic phosphatidylserine (PS) vesicles
or phosphatidylserine:phosphatidylcholine (PS:PC) mixed
vesicles. The negative charges of the vesicles prevent the close
approach of the pure PS. It is the total amount of positive
charge bound to the surface and the ionic strength of the
buﬀer solution [67] that participate in charge screening,
which in turn promotes vesicle aggregation. Studies have
shown that the onset of close apposition of bilayers and
hence fusion, directly depend on the destabilization of the
membranes, which is proportional to the number of Ca2+
bound to the membrane surface. Presence of Na+ in the
buﬀer competes with Ca2+ binding to anionic membrane
surface.AstheconcentrationofNa+ increasesinthesolution,
the value of Ca2+ bound per PS molecule is diminished,
which inhibits the Ca2+-induced fusion [60]. Experiments
have been done using small unilamellar vesicles (SUVs)
of PS or PS:PC mixed lipids. Theoretical studies and
Tb/DPA assay, as described earlier, are used to monitor
the fusion process [60]. Ca2+-induced fusion of PS vesicles
occurs at a threshold concentration of about 1mM [68]
when the number of Ca2+ bound per PS molecule at the
membrane surface is 0.40 [69, 70]. The process of fusion
increases signiﬁcantly above this threshold concentration.
For PS:PC mixed vesicles, since PC is neutral in nature,
there is a decrease in surface charge density which results
in lower number of Ca2+ associated per PS molecule. The
threshold concentration of Ca2+ is therefore higher, 2mM
for 4:1 PS:PC mixed vesicles in presence of 100mM Na+
solution, where the Ca2+ bound per PS molecule is 0.36. For
2:1 PS:PC mixed vesicles, the threshold concentration is
reportedtobe4-5mM,whereCa2+ boundperPSmoleculeis
0.38 [67]. Thus, presence of critical binding ratio is required
to initiate fusion in pure PS or PS:PC mixed vesicles. As theJournal of Lipids 5
binding of Ca2+ per PS molecule exceeds the threshold value
of 0.35–0.39, the fusion process is initiated. Table 1 shows
the binding ratio of Ca2+ per PS molecule available in the
literature [67], which will help in ﬁnding out the optimum
criteria for Ca2+-induced fusion under speciﬁc conditions.
Mg2+ also functions in a very similar way as Ca2+.
Since Mg2+ has lower binding constant with PS molecule
compared to that of Ca2+ [70, 71], the eﬀectiveness for
fusion of PS vesicles is lower in case of Mg2+. The threshold
concentration of Mg2+ in 2:1 PS:PC mixed vesicles is ∼
10mM and in pure PS vesicles is ∼6mM[59].
Along with Ca2+, all other divalent cations are expected
to follow a similar kind of mechanism of fusion. Although
charge screening is necessary for the close association of
the vesicles, but it is not suﬃcient to complete the fusion
of PS containing vesicles. During fusion induced by Ca2+
or any other divalent cations, there is also an increase of
membranesurface tensionresultinginlateralcompressibility
and structural defects [16, 56]. This change in PS membrane
surface is extremely necessary [49] for destabilization of the
lipid bilayer along with surface charge screening by cations.
Also, presence of Ca2+ or other divalent cations, the negative
PS headgroups readily absorb the positive divalent ions,
forming covalent bond through the carboxylate oxygen of
the PS headgroup (Figure 3). This uptake of cations by the
negatively charged sites of PS headgroups either cause the
removal ofstructural waterfromthemembrane surface [72],
or cause the formation of “trans” “divalent cation-phospha-
tidylserine” complex. This brings the negatively charged PS
headgroups close together; forcing the hydrocarbon phase
o ft h em e m b r a n e st of a c et h eh y d r o p h o b i cp h a s e[ 73, 74]
thereby promoting the HII phase formation thatis conducive
for membrane fusion.
2.1.2. Ca2+-Induced Fusion in Presence of Sulfatide. Other
than PS vesicles, where electrostatic or charge-charge inter-
action plays a critical role during fusion, Ca2+ is also able
to induce membrane fusion in vesicles containing lipids like
PE and so forth. It has been found that 10mM of Ca2+
enhances fusion of SUVs of dioleoylphosphatidylethanol-
amine (DOPE) containing less than 30 mole % sulfatides
(Figure 4)[ 75]. The progress of fusion is monitored using
two well-known assays, namely, NBD-PE/N-Rh-PE assay for
lipid mixing and Tb/DPA assay for content mixing. PE has
a natural tendency to fuse, but it is the negative charge
of the sulphate (SO4
2−) moiety of sulfatides that prevents
the inverted hexagonal (HII) phase formation in the DOPE
vesicles by interfacial hydration, and hence this leads to
the stabilization of the DOPE-sulfatide SUVs [76, 77]. The
binding of positively charged Ca2+ to the negatively charged
sulfatides not only neutralizes the negative charge present
on the membrane surface, but also reduces bound water,
thereby dehydrating the membrane surface [78]. This results
in the formation of nonlamellar intermediate as the PE
molecules revert back to the HII phase [79, 80]. Thus, fusion
occurs following similar “destabilization of the membrane
surface” mechanism as mentioned in case of pure Ca2+-
induced fusion.
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H+ also functions in a similar manner by charge neutral-
ization at low pH, which triggers dehydration and fusion.
The DOPE-sulfatide vesicle fusion is also a pH-dependent
phenomenon. At high concentration of sulfatides, that is, at
sulfatide concentration >3 0m o l% ,s t e r i ch i n d r a n c e[ 81–83]
of the sulfatide molecules on the membrane surface prevents
the proton-induced or Ca2+-induced hydration-dehydration
process. So, the fusion process is no longer pH-sensitive, and
the concentration of Ca2+ has no direct eﬀect. At such high
concentration of sulfatide (>30 mole %), the fusion process
decreases only with the increase in sulfatide concentration.
2.1.3. Ca2+-Induced Fusion in Presence of Other Fusogens.
Ca2+ ions are also found to induce fusion in biomembranes
like erythrocyte cell membranes [84]. In all cases where
Ca2+ is found to induce fusion of vesicle containing lipids
other than PS, diﬀerent active fusogens (either lipid-soluble
fusogens or water-soluble fusogens) are also required along
withCa2+.Inthesecases,Ca2+ onlyhelpsinmakingtheevent
faster and more eﬀective [85]. Both the lipid soluble-fuso-
gens (oleoylglycerol, dioleoylglycerol, trioleoylglycerol, etc.)
and water-soluble fusogens (polyethylene glycol, dimethyl
sulphoxide,etc.)makethemembranes more permeable[86].
T h ei n c r e a s ei np e r m e a b i l i t yo ft he membranes facilitates the
entryoftheCa2+ inthecell,andthisincreasedpartitioning of
Ca2+ enhancestheprocessoffusion.TheentryofCa2+ inery-
throcyte cells is monitored by measuring the radioactivity of
45Ca2+ inside and outside of the cell. Though the mechanism
ofactionofboththelipid-solubleandwater-solublefusogens
is diﬀerent, its actual aim is the same, that is, to increase
the permeability of the membranes. Lipid-soluble fusogens
inﬂuence the structure of the hydrocarbon chain and/or the
polar headgroups [87], and water-soluble fusogens aﬀect the6 Journal of Lipids
Table 1: Calculated amount of Ca2+ bound per PS in mixed PS/PC membranes [60].
Vesicle composition
(PS:PC)
Calculated tightly bound Ca2+ at various Ca2+ concentrations (in mM)
Na+ bulk concentration (in mM)
0.7 1.0 2.0 3.0 5.0 10.0
Pure PS 0.44 0.44 0.44 0.44 0.45 0.45 5
4:1 0.43 0.43 0.44 0.44 0.44 0.44 5
2:1 0.42 0.43 0.44 0.44 0.44 0.44 5
3:2 0.41 0.41 0.42 0.42 0.43 0.43 5
1:1 0.40 0.40 0.41 0.42 0.43 0.43 5
2:3 0.38 0.39 0.40 0.40 0.41 0.42 5
1:4 0.32 0.33 0.35 0.36 0.37 0.38 5
Pure PS 0.32 0.35 0.38 0.39 0.41 0.43 100
4:1 0.30 0.33 0.36 0.38 0.40 0.42 100
2:1 0.28 0.32 0.35 0.37 0.39 0.41 100
3:2 0.27 0.31 0.34 0.36 0.38 0.40 100
1:1 0.25 0.29 0.33 0.35 0.37 0.39 100
2:3 0.23 0.26 0.31 0.33 0.35 0.38 100
1:4 0.15 0.19 0.24 0.26 0.30 0.34 100
Pure PS 0.11 0.16 0.21 0.25 0.29 0.34 500
4:1 0.10 0.14 0.20 0.23 0.27 0.33 500
2:1 0.09 0.12 0.18 0.22 0.26 0.32 500
3:2 0.08 0.12 0.17 0.21 0.25 0.31 500
1:1 0.07 0.11 0.16 0.19 0.24 0.30 500
2:3 0.06 0.09 0.14 0.18 0.22 0.28 500
1:4 0.04 0.06 0.10 0.13 0.18 0.25 500
membrane surface potential and/or hydration of the polar
head groups [88] to increase the permeability of the bilayer.
2.1.4.MonovalentCation-Induced Fusion. Amongthemono-
valent cations, only H+ is found to induce membrane fusion.
H+ induces aggregation and ﬁnally fusion of vesicles having
negatively charged headgroups like PS SUVs [68, 89], PS
LUVs [65],andotherlipidvesicleslikePEliposomes[90,91],
PS:PE mixed SUVs [79], PE-oleic acid mixed multilamellar
vesicles [92], and PS-palmitoylhomocystein mixed SUVs
[93].
2.1.5. Trivalent Cation-Induced Fusion. A very new kind of
mechanism, which is known as “partition breakage model”
(Figure 5), where no stalk intermediate is formed, has been
proposed in case of fusion of neutral GUVs induced by
trivalent lanthanides, namely, La3+ or Gd3+ [64]. It has
been observed that DOPE and dioleoylphosphatidylcholine
(DOPC) mixed vesicle (30 DOPE:70 DOPC) undergo
membrane fusion on incorporation of 100µMo fL a 3+.
The process of fusion has been shown by phase contrast
imaging. After the merging of the GUVs, the density of the
incorporated La3+ is increased in the outer lipid layer (facing
the buﬀer). Due to this, the lateral compression pressure of
the outer monolayer increases. The presence of DOPE in
the GUVs favors the formation of HII (inverted hexagonal)
phase, and La3+ stabilizes this HII phase hence, the area of
the outer monolayer is decreased. Thus, the chain packing,
mostly at the edge of partition membrane, is destabilized
causing the breakage of the membrane at the edge. Then, the
area of this breakage site increases, and ﬁnally the partition
membrane gets ruptured. This is a unique example where
membrane fusion occurs directly starting from merging of
the vesicles without the formation of any hemifusion (stalk-
like) intermediate. Moreover, the partition membrane that
hasseparatedfromtheGUVsduringfusionformsatinySUV
and resides inside the fused vesicle. That is why the area of
the membrane of the fused vesicle will be decreased due to
the loss of partition membrane.
2.2. Small Organic Molecule
2.2.1. n-Hexyl Bromide. During the early eighties, small
molecules belonging to the n-alkyl bromide group
[CnH2n+1Br; n ≥ 6 ]w a sf o u n dt oa c ta sf u s o g e n i ca g e n t s .
Among them n-hexyl bromide (Figure 6; n = 6), octyl
bromide (n = 8), and decyl bromide (n = 10) are known to
have the desired fusogenic property [94]. These molecules
can induce fusion at a very low molecule-to-lipid ratio
(M:L) of 0.05 (for n = 6) [95], and they can induce
cellular or subcellular membrane fusion [96] along with the
fusion of biomimetics like PC-phosphatidic acid (PC:PA)
mixed vesicles. Multilamellar vesicles (MLVs) of PC or
PC:PA mixed lipids are used for experiments. Electron
microscopy and freeze fracture microscopy images are
shown to prove the successful completion of the fusion
process [95]. Moreover, incorporation of very low amount
of these organic molecules, for example, about 2.5µMJournal of Lipids 7
(1) (2) (3) (4)
Figure 5: Schematic diagram of the partition breakage model. The arrows in (1) show the La3+-induced lateral compressionpressure of the
membranes,and the green triangle in (2) showsthe interstitial hydrocarbon region where free energy of chain packingis very large. Adapted
from reference [64].
H3C Br
Figure 6: n-hexyl bromide.
of n-hexyl bromide/50µM lipid/mL does not alter the
constitution, cell viability, or the ion transport properties of
the membranes [95]. The fusion of vesicles was shown by
electron microscopy images. A signiﬁcant increase in the size
of the vesicles due to the incorporation of n-hexyl bromide
was shown [94, 95] as proof of fusion.
In the early eighties, the small molecules that act as
fusogenic agents were mostly metal ions. The only estab-
lished mechanism, which was considered to be true at
that time, was based on initial charge-charge interaction,
charge neutralization, dehydration of membrane surface,
and destabilization of the lipidic bilayer leading to fusion
[49]. The mechanism followed by n-hexyl bromide was
diﬀerentfrom themechanism thatwas common. Thatis why
in the literature, the elucidation of mechanism of membrane
fusion induced by n-hexyl bromide was mainly conﬁned to
showing that charge-charge interaction did not participate
during thefusion process. Nodetailedmechanism of n-hexyl
bromide-induced fusion was given. However, it was shown
that ﬂuidity of the membrane was a prerequisite for fusion.
2.2.2. Short-Chain Alcohols—Ethanol. Short-chain alcohols
are found to induce the hemifusion process which ﬁnally
leads the process to fusion. It is already known that general
fusogens induce the formation of the HII phase, which
in turn stabilizes the hemifusion intermediate to promote
fusion. Short-chain alcohols are expected to work diﬀerently.
Alcohols, mostly methanol and ethanol (Figure 7), do not
alter the curvature of the membrane bilayer. Both methanol
and ethanol apparently support positive spontaneous cur-
vature of lipid monolayers [97, 98]. That is why it is
highly unlikely for them to induce the formation of the HII
phase. Researchers have found that short-chain alcohols like
ethanol can induce the formation of the hemifusion or stalk
intermediate in GUVs [99]. Moreover, ethanol is reported
to induce the fusion of PC SUVs [100]. Imaging techniques
like ﬂuorescence microscopy and freeze fracture electron
H3C OH
Figure 7: Ethanol.
microscopy were used to monitor the fusion processes.
Both the authors pointed that it was not the HII phase
formation but the destabilization of the outer membrane
monolayer that led the process to complete fusion. During
the formation of hemifusion or stalk intermediate, it was
proposedthatshort-chain alcoholsdisruptedtheouterleaﬂet
of lipid layer to cause the local breakage of the monolayer
to induce the stalk formation [99]. During stalk formation,
thehydrophobicvoidsare created betweenthebilayerleaﬂets
[101]. It was proposed that ethanol aﬀe c t e dt h el i p i dc h a i n
packing in the void region to decrease the energy of the
hydrophobic voids to stabilize the stalk intermediate [102].
Moreover, a very high concentration of ethanol was pro-
posed to form interdigitated state in the contacting region
of the membranes. Interdigitated state formation led the hy-
drophobic acyl chain terminal to be exposed on the sur-
face of the membranes, which increased the hydrophobic
interaction between two contacting interdigitated bilayers.
This resulted in the high stability of the aggregated lipids,
which led the process to lipid mixing and ﬁnally to successful
content mixing [100].
2.3. Plant Hormone—Abscisic Acid. In the early nineties,
another small molecule was found that can act as an
eﬀective fusogen, namely, a plant hormone, abscisic acid
(ABA; Figure 8). It was found to promote fusion of vesicles
consisting of a mixture of 9:1 PC:PE lipids at an ABA
molecule-to-lipid ratio (M:L ratio) of 0.125 [103].
Though pure PC vesicles did not undergo fusion in
presenceofABA,butat9:1PC:PE,vesiclesstarttofuseatan
M:L ratio of 0.125 and the process of fusion increases as the
M:L ratio increase from 0.125 to 0.50. Moreover, the fusion
process also increased with the increase in the PE concentra-
tion in the mixed vesicles. All the fusion experiments were
done using MLVs of dimyristoylphosphatidylcholine-dim-
yristoylphosphatidylethanolamine (DMPC/DMPE) mixed
lipids at pH 5.0. ANTS/DPX assay was used to probe the8 Journal of Lipids
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Figure 8: Abscisic Acid.
mixing of the inner contents, and the NBD-PE/N-Rh-PE
assay was used to probe the lipid mixing [103]. From these
ﬁndings, it was evident that the presence of PE in the vesicles
was essential for the initiation of fusion induced by ABA.
PE is an intrinsically fusogenic lipid due to its capability
of forming of HII phase [104]. That is why PC-PE mixed
vesicles are considered to be inherently unstable and capable
of undergoing fusion spontaneously. Incorporation of PE in
PC vesicles creates various sites of defects or perturbations
i nt h em e m b r a n eb i l a y e r[ 105]. Mostly, the mismatch in
headgroup size of the two phospholipids results in packing
defects. It has been shown that ABA acts in these small
regions ofmembrane defects. Sincethe working temperature
is above the transition temperature of PC, but below that
of PE, there are regions of interface between gel and liquid
crystalline domains. ABA also occupies these interfaces
[106]. After the two approaching membrane overcome the
electrostatic, van der Waal’s and hydration repulsion, a tran-
sient destabilization occur at the region of contact of the two
membranes [107] which is enhanced by ABA.This enhanced
destabilization causes a local dehydration, making the HII
phase formation a stable process and the bilayer structure of
the membranes gets disrupted [108]. Finally, the size of the
defect site is elongated and thus membrane permeability is
also increased. This leads to aggregation of the lipids and to
successful completion of fusion.
2.4. Small Drug Molecules
2.4.1. Halothane-Induced Fusion. Halothane (Figure 9)i s
a small drug molecule that can act as an anesthetic [51].
Two-photon ﬂuorescence correlation spectroscopy was used
to show that LUVs of DOPC undergo fusion in presence of
halothane.However,fusioncanoccuronlyatveryhigh drug-
to-lipid ratio (D:L) of 10.
Two-photon ﬂuorescence correlation spectroscopy and
ANTS/DPXassay for content mixing were done to probe the
process of fusion. Halothane was heterogeneously incorpo-
rated in the bilayer just below the head group region of the
lipids[109,110].This incorporationofhalothanein thelipid
bilayer causes the increase in the interlipid spacing. With
increase in lipid spacing, random collision between vesicles
become less elastic because lipid headgroups from each
vesicles may interpenetrate which promotes the aggregation.
Also, the void-ﬁlling eﬀect of halothane would lower the
energy of intermediate stalk formation [111], facilitating the
fusion.
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Figure 10: Oxicam NSAIDs: meloxicam (a), piroxicam (b) and
tenoxicam (c).
2.4.2. Oxicam NSAIDs-Induced Fusion. The most recent dis-
covery in the series of small molecule fusogens are the
painkillers belonging to the oxicam groups of nonsteroidal
anti-inﬂammatory drugs (NSAIDs). These drugs were orig-
inally developed to combat pain and inﬂammation but have
been shown to have other functions as chemopreventive and
chemosupressiveagents[112–114].Three drugsbelongingto
the oxicam groups of NSAIDs, namely, meloxicam, pirox-
icam, and tenoxicam (Figure 10)a r ef o u n dt oa c ta s
membrane fusogens [115]. They are eﬀective fusogens not
only for membrane mimetics like lipid vesicles, but also for
biomembranes like mitochondrial membrane. One of the
drugs, piroxicam, was found to permeabilize mitochondrial
membrane in V79 Chinese hamster lung ﬁbroblast, at phys-
iological concentration, leading to the release of cytochrome
Ci nt h ec y t o s o lt h a ti nt u r ns i g n a l l e dt h ed o w n s t r e a mp r o -
apoptotic caspase-3 [116].
A closer look showed that membrane fusion is not a
property of piroxicam alone but is also shared by two other
oxicam painkillers, namely, meloxicam and tenoxicam[115].
The three drugs can induce membrane fusion at physiolog-
ically relevant concentration [117] whereas NSAIDs belong-
ing to other chemical groups do not share this property.
There lies an immense potential for application of these
drugs as inducers of membrane fusion. Understanding the
mechanistic details of these NSAIDs-induced fusion will
allow the use of these painkillers to fuse membranes in
a controlled manner as is necessary in many biochemi-
cal/biotechnological processes. To identify and parse the
eﬀect of diﬀerent physical and chemical parameters of bothJournal of Lipids 9
the participating drugs and lipids, simple membrane mimet-
ics like SUVs, formed from phospholipid DMPC, were used.
The kinetics of lipid mixing, content mixing, and leakage
werefollowedbystandardﬂuorescenceassays,namely,NBD-
PE/N-Rh-PE assay for lipid mixing and Tb/DPA assay for
content mixing. These were coupled with direct imaging
of fused vesicles with TEM. Temperature-dependent studies
and concentration-dependent studies showed that, unlike
the other small molecules, these drugs can induce fusion
at a very low drug-to-lipid ratio of 0.018. The lipid mixing
and content mixing are two sequential events, and the
activation energy of both processes is lowered compared
to smaller diameter vesicles, which promotes fusion. Eﬀects
of low concentration of cholesterol (<10mol%) have also
been studied in DMPC SUVs above the sol-gel transition
of DMPC. It is known that under these conditions, there
is an increase in orientational order of the lipids as well as
an increase in headgroup spacing. The eﬀect of these two
membrane parameters counteract on the fusion process. The
eﬀect of orientational order dominates in case of meloxicam
and piroxicam, leading to a decrease in the overall fusion
process, but in case of tenoxicam, increase in headgroup
spacing increases partitioning of the drug which nulliﬁes the
eﬀect of orientational order [118].
The fact that these drugs are eﬀective fusogens at such
low drug-to-lipid ratio is a unique observation, when one
considers that SUVs of DMPC are used. Phospholipids with
PC headgroup are not known to have intrinsic tendency to
fuse like PE headgroups [103]. Besides, SUVs having 50–
60nm diameter as used in this case do not have enough
material to form the inverted hexagonal phase (HII)t h a t
promotes fusion [27, 119]. It should be mentioned that
carefully designed controls in absence of the drugs showed
that no fusion was taking place within the experimental
time frame. This ruled out the fact that the high curvature
of the SUV could induce spontaneous fusion. It is known
that introduction of defects or membrane perturbation,
either by external organic molecules or by changing physical
parameters, can promote fusion [27]. In a previous work by
the authors, where interaction of these three oxicam NSAIDs
with DMPC monolayer was studied at air water interphase,
it was found that in the same concentration range, the drugs
were capable of perturbing the monolayer such that the
monolayer plane was no longer well deﬁned [120]. It is the
perturbing ability of the drugs at such a low concentration
r a n g et h a tc a nb eo n ep o s s i b l er e a s o nw h yt h e s ed r u g sa r e
eﬀective membrane fusogens.
2.4.3. Chlorpromazine-Induced Fusion. Chlorpromazine
(CPZ;Figure 11)isa prototypicalphenothiazine antipsycho-
tic drug. CPZ can induce fusion of human red blood cells
and viral envelopes without the aid of fusogenic proteins.
However, this is achieved only when CPZ forms micelle-like
aggregates [121–123]. Transmission electron microscopy
(TEM), scanning electron microscopy (SEM), and so forth
are used to have the images of fused vesicles. It has been
found that at a concentration (2mM) which is slightly less
than the critical miceller concentration (CMC = 4mM)
of CPZ, it is able to fuse human RBC at pH higher than
S
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Figure 11: Chlorpromazine.
6.8. These molecules act in the protein-free region of the
membranes and cause fusion in the nonprotein site of the
membranes [122].
Electronmicrographs[124,125]clearlyshowedthatmic-
rodroplets of chlorpromazine adhere to the membrane
surface of human RBC to form fused bodies. However, it
is not established whether it is the microdroplets or smaller
micelles that initiate the fusion process. CPZ has very good
aﬃnity for the RBC membranes, and it is intercalated inside
the cytoplasmic half of the membrane bilayer. This results in
theexpansion oftheinnermonolayeroftheRBCmembrane,
which destabilizes the bilayer that leads the process of fusion
to successful completion [126, 127].
3.ConcludingRemarks
The process of membrane fusion mediated by proteins/
peptides is very diﬀerent from that mediated by small
molecules and ions. As we have already discussed, the basic
diﬀerence that exists between these two types of fusion lies
in their diﬀerence in the process of harnessing the energy
required for overcoming the diﬀerent intermediate steps of
the fusion process. For protein/peptide-induced fusion, this
energy is provided by the structural reorganization of the
big molecules. Small molecules or ions do not have this
advantage, as their structural reorganization is not expected
to supply the required driving force. The mechanism for
the process of fusion induced by small molecules/ions
varies to some extent depending on the nature of the
fusogen, though the basic steps of the fusion process remain
similar. In general, small molecules get partitioned inside
the membrane (or hydrophobic lipid phase) and cause
a destabilization of the lipid bilayer. This destabilization
manifests in membrane perturbation in diﬀerent ways,
depending on the nature of the small molecules. This per-
turbation may increase the permeability of the membranes,
may make the collision between the vesicles more sticky,
may increase the surface tension, or may even help in
forming the inverted hexagonal phase (HII) formation. Any
of these changes will help in inducing fusion. In case of ion-
induced fusion, the primary eﬀect is dependent on charge
screening, where charge neutralization of the anionic lipid
head groups by the cations promotes aggregation of the
lipid vesicles and ﬁnally fusion occurs. However, in many
cases, charge screening is found to be necessary but not10 Journal of Lipids
Table 2: Relation of the fusogenic molecules with its threshold concentration and size. For the determination of the length and width of the
molecules, all the geometries are minimized using a semiempirical level of theory, Austin Model 1 (AM1) using GAUSSIAN 03 [128]. AM1
is based on a modiﬁed neglect of diﬀerential overlap (MNDO) approximation [129].
Molecules Length (in nm) Width (in nm) Molecule-to-lipid ratio at threshold concentration Vesicle size
Abscisic acid 1.04 0.68 0.125 MLV (∼1000nm)
n-hexyl bromide 0.88 0.25 0.050 SUV (30–40nm)
Ethanol 0.40 0.23
Halothane 0.42 0.30 10.0 LUV (∼500nm)
Meloxicam 1.43 0.60 0.018 SUV (50–60nm)
Piroxicam 1.38 0.61 0.018 SUV (50–60nm)
Tenoxicam 1.23 0.54 0.018 SUV (50–60nm)
Chlorpromazine 1.06 1.01 6000–8000nm
O
CH3
CH3
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Figure 12: Ibuprofen.
as u ﬃcient condition for the complete fusion. Additional
factors like change in surface tension, surface hydration, and
so forth, participate along with charge screening to lead the
fusion to completion. This mechanism is diﬀerent from the
mechanism of small molecule-induced fusion as mentioned
above. Table 2, shows the threshold concentration of small
molecules that is required to trigger membrane fusion.
This has been compared with their dimension. Signiﬁcant
correlation exists between the concentration of the small
molecules required for destabilization of the membrane
bilayer, with their dimension. Even though there exists a
correlation between moleculardimension and concentration
of destabilization, it is not the only decisive factor. Molecules
having similar dimension like ibuprofen (Figure 12)d on o t
show fusion [115].
Thisisbecauseitperturbsthemembranebilayersomuch
that leakage predominates in such way that fusion cannot
occur. For a small molecule to act as an eﬀective membrane
fusogen, not only the dimension but also the chemical
nature should be such that the lipid bilayer perturbation
should not result in overwhelming leakage that prevents
fusion.
There exists a gap in our knowledge in understanding
the mechanism of how diﬀerent small molecules and ions
can induce membrane fusion and how the nature of these
fusogens will dictate the process. A lot of work needs to
be done to bridge this gap in our knowledge which is
necessary to replace proteins and peptides by small fusogens
for controlling fusion both in vivo and in vitro systems
which will make the process more cost eﬀective and easy to
handle.
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